MRNA - Why CBAK Energy Technology Stock Soared by Almost 84% Monday
Even on a day like Monday, when excellent news out of Moderna (NASDAQ: MRNA) -- interim results from a phase 3 study of its coronavirus vaccine candidate show it to be 94.5% effective -- turned most stock market averages green, the performance of CBAK Energy (NASDAQ: CBAT) stock was kind of mind-blowing.
During a frenzy of morning trading, shares of the Chinese lithium battery-maker soared by more than 72%, before retreating somewhat, then surging back in the final half-hour to end the day up by 83.7%.
And so far as I can tell, CBAK stock made this run-up on no news at all.
For further details see:
Why CBAK Energy Technology Stock Soared by Almost 84% Monday